United States · Bill · S
S. 3092 (116th)
Expanding Access to Low-Cost Generics Act of 2019
Introduced
18 December 2019
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
—
Subjects
Discovery layer
Source updated
21 April 2025
Summary
Expanding Access to Low-Cost Generics Act of 2019 This bill modifies the 180-day exclusivity period for certain generic drug manufacturers.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 18 December 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 18 December 2019
Introduced in Senate
summary · EN · 18 December 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/3092
- Open data entity: https://api.congress.gov/v3/bill/116/s/3092